ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC35431-10mM (in 1mL DMSO) |
|
12192-57-3 |
Aurothioglucose
|
0 | C6H11AuO5S | |
GC35430-10mg |
|
163768-50-1 |
Auristatin F
|
0 | C40H67N5O8 | |
GC35430-5mg |
|
163768-50-1 |
Auristatin F
|
0 | C40H67N5O8 | |
GC35430-1mg |
|
163768-50-1 |
Auristatin F
|
0 | C40H67N5O8 | |
GC35430-10mM (in 1mL DMSO) |
|
163768-50-1 |
Auristatin F
|
0 | C40H67N5O8 | |
GC35429-10mg |
|
160800-57-7 |
Auristatin E
|
0 | C40H69N5O7 | |
GC35429-5mg |
|
160800-57-7 |
Auristatin E
|
0 | C40H69N5O7 | |
GC35429-1mg |
|
160800-57-7 |
Auristatin E
|
0 | C40H69N5O7 | |
GC35428-100mg |
|
55-48-1 |
Atropine sulfate
|
0 | C17H23NO3 . 1/2 H2O4S | |
GC35427-100mg |
|
2870-71-5 |
Atropine methyl bromide
|
0 | C18H26BrNO3 | |
GC35427-50mg |
|
2870-71-5 |
Atropine methyl bromide
|
0 | C18H26BrNO3 | |
GC35427-10mg |
|
2870-71-5 |
Atropine methyl bromide
|
0 | C18H26BrNO3 | |
GC35427-10mM (in 1mL DMSO) |
|
2870-71-5 |
Atropine methyl bromide
|
0 | C18H26BrNO3 | |
GC35426-5mg |
|
— |
Atrial Natriuretic Peptide (ANP) (1-28), rat TFA
|
0 | C130H206N45F3O41S2 | |
GC35426-1mg |
|
— |
Atrial Natriuretic Peptide (ANP) (1-28), rat TFA
|
0 | C130H206N45F3O41S2 | |
GC35426-500μg |
|
— |
Atrial Natriuretic Peptide (ANP) (1-28), rat TFA
|
0 | C130H206N45F3O41S2 | |
GC35424-50mg |
|
173937-91-2 |
Atrasentan
|
0 | C29H38N2O6 | |
GC35424-10mg |
|
173937-91-2 |
Atrasentan
|
0 | C29H38N2O6 | |
GC35424-5mg |
|
173937-91-2 |
Atrasentan
|
0 | C29H38N2O6 | |
GC35424-2mg |
|
173937-91-2 |
Atrasentan
|
0 | C29H38N2O6 | |